Dobutamine stress echocardiography and the effect of revascularization on outcome in diabetic and non-diabetic patients with chronic ischaemic left ventricular dysfunction

European Journal of Heart Failure

Volumn 9, Issue 10, 2007, Pages 1038-1043

  Cortigiani, Lauro ^a   Sicari, Rosa ^b   Desideri, Alessandro ^c   Bigi, Riccardo ^d   Bovenzi, Francesco ^a   Picano, Eugenio ^b  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c S Giacomo Hospital   (Italy)

^d University School of Medicine   (Italy)

Author keywords

Coronary artery disease; Diabetes mellitus; Prognosis; Stress echocardiography

Indexed keywords

DOBUTAMINE;

ADULT; ANGIOGRAPHY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; STRESS ECHOCARDIOGRAPHY;

CASE-CONTROL STUDIES; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548820721     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.07.002     Document Type: Article

References (36)

1. Emond M., Mock M.B., Davis K.B., et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 90 (1984) 2645-2657
2. Braunwald E., and Rutherford J.D. Reversible ischemic left ventricular dysfunction: evidence for "hibernating" myocardium. J Am Coll Cardiol 8 (1986) 1467-1470
3. Rahimtoola S.H. The hibernating myocardium. Am Heart J 117 (1989) 211-213
4. Bonow R.O. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol 75 (1995) 17A-25A
5. Gersh B.J., Kronmal R.A., Schaff H.V., et al. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry. N Engl J Med 313 (1985) 217-224
6. Meluzin J., Cezny J., Frelich M., et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 32 (1998) 912-920
7. Afridi I., Grayburn P.A., Panza J.A., Oh J.K., Zoghbi W.A., and Marwick T.H. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 32 (1998) 921-926
8. Senior R., Kaul S., and Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 33 (1999) 1848-1854
9. Sawada S., Bagat A., Vaz D., et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgical revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 42 (2003) 2106-2108
10. Bax J.J., Poldermans D., Elhendy A., et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 34 (1999) 163-169
11. Chaudry F.A., Tauke J.T., Alessandrini R.S., Vardi J., Parker M.A., and Bonow R.O. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 34 (1999) 730-738
12. Sicari R., Picano E., Cortigiani L., et al. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 92 (2003) 1263-1266
13. Pasquet A., Robert A., D'Hondt A.M., Dion R., Melin J.A., and Vanovershelde J.L. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 100 (1999) 141-148
14. Rizzello V., Poldermans D., Biagini E., et al. Benefits of coronary revascularization in diabetic and non-diabetic patients with ischemic cardiomyopathy: role of myocardial viability. Eur J Heart Fail 8 (2006) 314-320
15. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1999) 1414-1431
16. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434
17. Haffner S.M., Letho S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
18. Cortigiani L., Bigi R., Sicari R., Landi P., Bovenzi F., and Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 47 (2006) 605-610
19. Herlitz J., Wognsen G.B., Emanuelsson H., et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 19 (1996) 698-703
20. Carson J.L., Scholz P.M., Chen A.Y., Peterson E.D., Gold J., and Schneider S.H. Diabetes mellitus increases short-mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40 (2002) 418-423
21. World Health Organization: diabetes mellitus. Report of a WHO study group. Tech. Rep. Ser. vol. 727 (1985), World Health Org., Geneva
22. The sixth report on the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413-2446
23. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
24. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
25. Picano E., et al., on behalf of the EDIC Study Group. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large scale, multicenter trial. Lancet 344 (1994) 1190-1192
26. Lauer M.S., Blackstone E.H., Young J.B., and Topol E.J. Cause of death in clinical research: time for a reassessment?. J Am Coll Cardiol 34 (1999) 618-620
27. Shindler D.M., Kostis J.B., Yusuf S., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 77 (1996) 1017-1020
28. McKelvie R.S., Yusuf S., Pericak D., et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 100 (1999) 1056-1064
29. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and the impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
30. Samady H., Elefteriades J.A., Abbott B.G., Mattera J.A., McPherson C.A., and Wackers F.J. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 100 (1999) 1298-1304
31. Tarakji K.G., Brunken R., McCarthy P.M., et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 113 (2006) 230-237
32. Holmes Jr. D.R., Davis K.B., Mock M.B., et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation 73 (1986) 1254-1263
33. Rizzello V., Poldermans D., Boersma E., et al. Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 110 (2004) 2383-2388
34. Yong Y., Nagueh S.F., Shimoni S., et al. Deceleration time in ischemic cardiomyopathy. Relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization. Circulation 103 (2001) 1232-1237
35. Cooper S., and Caldwell J.H. Coronary artery disease in people with diabetes: diagnostic and risk factor evaluation. Clin Diabetes 17 (1999) 58-72
36. Cortigiani L., Picano E., Landi P., et al. Value of pharmacological stress echocardiography in risk stratification of patients with single-vessel disease. A report from the echo-persantine and echo-dobutamine international cooperative studies. J Am Coll Cardiol 32 (1998) 69-74